Sheila Spada

1.4k total citations
21 papers, 835 citations indexed

About

Sheila Spada is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Sheila Spada has authored 21 papers receiving a total of 835 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 10 papers in Molecular Biology and 10 papers in Immunology. Recurrent topics in Sheila Spada's work include Cancer Immunotherapy and Biomarkers (7 papers), Immune Cell Function and Interaction (5 papers) and Immunotherapy and Immune Responses (5 papers). Sheila Spada is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Immune Cell Function and Interaction (5 papers) and Immunotherapy and Immune Responses (5 papers). Sheila Spada collaborates with scholars based in United States, Italy and Malaysia. Sheila Spada's co-authors include Sandra Demaria, Nils-Petter Rudqvist, Paola Nisticò, Francesca Di Modugno, Silvia C. Formenti, Claire Vanpouille‐Box, Julie M. Diamond, Karsten A. Pilones, Yasmeen Sarfraz and Beatrix Ueberheide and has published in prestigious journals such as Nature Communications, Cancer Research and Oncogene.

In The Last Decade

Sheila Spada

20 papers receiving 830 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sheila Spada United States 11 378 370 369 176 92 21 835
Hiep Phuc Dong Norway 18 380 1.0× 327 0.9× 283 0.8× 177 1.0× 183 2.0× 33 928
Bradley N. Bidwell Australia 5 429 1.1× 290 0.8× 279 0.8× 179 1.0× 69 0.8× 8 751
Hyung‐Gyoon Kim United States 17 405 1.1× 541 1.5× 197 0.5× 189 1.1× 134 1.5× 33 1.0k
Stéphanie Corgnac France 16 748 2.0× 339 0.9× 938 2.5× 104 0.6× 108 1.2× 28 1.3k
Hugues J. M. Nicolay Italy 10 289 0.8× 637 1.7× 386 1.0× 99 0.6× 65 0.7× 14 917
Yumi Kinugasa‐Katayama Japan 5 325 0.9× 263 0.7× 577 1.6× 116 0.7× 76 0.8× 7 898
Giuseppina Barutello Italy 16 173 0.5× 282 0.8× 233 0.6× 124 0.7× 143 1.6× 29 675
Anusha-Preethi Ganesan United States 6 581 1.5× 297 0.8× 639 1.7× 111 0.6× 112 1.2× 9 1.0k
Yuan‐Tong Liu China 14 384 1.0× 319 0.9× 365 1.0× 136 0.8× 146 1.6× 18 894
Iva Truxová Czechia 16 648 1.7× 299 0.8× 729 2.0× 94 0.5× 104 1.1× 24 1.2k

Countries citing papers authored by Sheila Spada

Since Specialization
Citations

This map shows the geographic impact of Sheila Spada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheila Spada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheila Spada more than expected).

Fields of papers citing papers by Sheila Spada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheila Spada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheila Spada. The network helps show where Sheila Spada may publish in the future.

Co-authorship network of co-authors of Sheila Spada

This figure shows the co-authorship network connecting the top 25 collaborators of Sheila Spada. A scholar is included among the top collaborators of Sheila Spada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheila Spada. Sheila Spada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Belmonte, Beatrice, Sheila Spada, Paola Allavena, et al.. (2025). Highlighting recent achievements to advance more effective cancer immunotherapy. Journal of Experimental & Clinical Cancer Research. 44(1). 57–57. 1 indexed citations
2.
Ganeeva, Irina, et al.. (2025). Allogeneic NKG2D CAR-T Cell Therapy: A Promising Approach for Treating Solid Tumors. Biomedicines. 13(9). 2314–2314.
3.
Valiullina, Aygul, et al.. (2024). Breaking the shield of solid tumors: a combined approach for enhanced efficacy of CAR-T cells. Cancer Immunology Immunotherapy. 74(1). 3–3. 4 indexed citations
4.
Ganguly, Anirban, et al.. (2024). Factors affecting heterogeneity in breast cancer microenvironment: A narrative mini review. International review of cell and molecular biology. 385. 211–226. 3 indexed citations
5.
Ganguly, Anirban, et al.. (2023). Targets of Immune Escape Mechanisms in Cancer: Basis for Development and Evolution of Cancer Immune Checkpoint Inhibitors. Biology. 12(2). 218–218. 82 indexed citations
6.
Rudqvist, Nils-Petter, Maud Charpentier, Claire Lhuillier, et al.. (2023). Immunotherapy targeting different immune compartments in combination with radiation therapy induces regression of resistant tumors. Nature Communications. 14(1). 5146–5146. 32 indexed citations
7.
Spada, Sheila. (2023). Methodologies to evaluate the radiation-induced changes on extracellular vesicles. Methods in cell biology. 180. 39–48. 1 indexed citations
8.
Charpentier, Maud, et al.. (2022). Radiation therapy-induced remodeling of the tumor immune microenvironment. Seminars in Cancer Biology. 86(Pt 2). 737–747. 72 indexed citations
9.
Spada, Sheila, et al.. (2021). Fibronectin as a multiregulatory molecule crucial in tumor matrisome: from structural and functional features to clinical practice in oncology. Journal of Experimental & Clinical Cancer Research. 40(1). 102–102. 99 indexed citations
10.
Wennerberg, Erik, Sheila Spada, Nils-Petter Rudqvist, et al.. (2020). CD73 Blockade Promotes Dendritic Cell Infiltration of Irradiated Tumors and Tumor Rejection. Cancer Immunology Research. 8(4). 465–478. 103 indexed citations
11.
Spada, Sheila, Nils-Petter Rudqvist, & Erik Wennerberg. (2020). Isolation of DNA from exosomes. Methods in enzymology on CD-ROM/Methods in enzymology. 636. 173–183. 10 indexed citations
12.
Melchionna, Roberta, Sheila Spada, Francesca Di Modugno, et al.. (2020). The actin modulator hMENA regulates GAS 6‐ AXL axis and pro‐tumor cancer/stromal cell cooperation. EMBO Reports. 21(11). e50078–e50078. 27 indexed citations
13.
Wennerberg, Erik, Nils-Petter Rudqvist, & Sheila Spada. (2020). Characterization of conventional dendritic cell populations in preclinical tumor models using flow cytometry. Methods in enzymology on CD-ROM/Methods in enzymology. 635. 139–148. 1 indexed citations
14.
Spada, Sheila, Takahiro Yamazaki, & Claire Vanpouille‐Box. (2019). Detection and quantification of cytosolic DNA. Methods in enzymology on CD-ROM/Methods in enzymology. 629. 17–33. 7 indexed citations
15.
Diamond, Julie M., Claire Vanpouille‐Box, Sheila Spada, et al.. (2018). Exosomes Shuttle TREX1-Sensitive IFN-Stimulatory dsDNA from Irradiated Cancer Cells to DCs. Cancer Immunology Research. 6(8). 910–920. 283 indexed citations
16.
Modugno, Francesca Di, Sheila Spada, Belinda Palermo, et al.. (2018). hMENA isoforms impact NSCLC patient outcome through fibronectin/β1 integrin axis. Oncogene. 37(42). 5605–5617. 15 indexed citations
17.
Timperi, Eleonora, Chiara Focaccetti, Sheila Spada, et al.. (2017). IL-18 receptor marks functional CD8+ T cells in non-small cell lung cancer. OncoImmunology. 6(7). e1328337–e1328337. 26 indexed citations
18.
Trono, Paola, Francesca Di Modugno, Sheila Spada, et al.. (2015). hMENA11a contributes to HER3-mediated resistance to PI3K inhibitors in HER2-overexpressing breast cancer cells. Oncogene. 35(7). 887–896. 13 indexed citations
19.
Trono, Paola, Francesca Di Modugno, Sheila Spada, et al.. (2015). Abstract 4316: hMENA11a contributes to HER3-mediated resistance to PI3K inhibitors in HER2 overexpressing breast cancer cells. Cancer Research. 75(15_Supplement). 4316–4316. 1 indexed citations
20.
Nisticò, Paola, Francesca Di Modugno, Sheila Spada, & Mina J. Bissell. (2014). β1 and β4 integrins: from breast development to clinical practice. Breast Cancer Research. 16(5). 459–459. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiep Phuc Dong Breakdown of academic impact, for papers by Bradley N. Bidwell Breakdown of academic impact, for papers by Hyung‐Gyoon Kim Breakdown of academic impact, for papers by Stéphanie Corgnac Breakdown of academic impact, for papers by Hugues J. M. Nicolay Breakdown of academic impact, for papers by Yumi Kinugasa‐Katayama Breakdown of academic impact, for papers by Giuseppina Barutello Breakdown of academic impact, for papers by Anusha-Preethi Ganesan Breakdown of academic impact, for papers by Yuan‐Tong Liu Breakdown of academic impact, for papers by Iva Truxová
Rankless by CCL
2026